MEMBRANE EXPRESSION OF NK RECEPTOR KIR3DL2 CONTRIBUTES TO DELINEATE THE ACUTE‐TYPE AND IS A THERAPEUTIC TARGET IN ADULT T‐CELL LEUKEMIA/LYMPHOMA
Gespeichert in:
| Veröffentlicht in: | Hematological oncology 2019-06, Vol.37 (S2), p.271-272 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 272 |
|---|---|
| container_issue | S2 |
| container_start_page | 271 |
| container_title | Hematological oncology |
| container_volume | 37 |
| creator | Cheminant, M. Lhermitte, L. Bruneau, J. Sicard, H. Bonnafous, C. Ortonne, N. Genestier, L. Gaulard, P. Palmic, P. Dussiot, M. Waast, L. Avettand‐Fenoel, V. Brouzes, C. Lepelletier, Y. Asnafi, V. Marçais, A. Hermine, O. |
| description | |
| doi_str_mv | 10.1002/hon.82_2630 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2242712203</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2242712203</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1080-ab27df1fb029c6a5b6f76e5c461f5863ec2c0e11851c5b19a5c12d4c8b8b50773</originalsourceid><addsrcrecordid>eNp9kM1K5EAQx5tFYceP075AwR4lWt2ZfB3bTOk00_kg04H11CRtwirqaLKyePMRPPiEPomR0aunour_qyr4MfaL4zFHFCd_N3fHsbAi9PEHm3FMEo9jmOywGYoo9lD44ifbG8drxCnDeMZeM8pOK5kT0J-yovVaFTkUZ5CvoKKUSlNUsFKVv9AC0iI3lTqtDa3BFLAgrXKShsAsCWQ6zd-eX8xFOTX5AtQa5EdSyZJqo1IwsjonAyoHuai1ATPRKWkNmuoVZUqe6IusXBaZPGC7fXMzdoefdZ_VZ2TSpaeLc5VK7TmOMXpNK6LLnvctisSFTdCGfRR2gZuHvA_i0O-ccNhxHgfcBS1PmsBxcTl3cRu3AUaRv89-b-_eD5uHx278Z683j8Pd9NIKMRcRFwL9iTraUm7YjOPQ9fZ-uLpthifL0X5ot5N2-6l9ov0t_f_qpnv6DrXLIv_aegcto3tF</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2242712203</pqid></control><display><type>article</type><title>MEMBRANE EXPRESSION OF NK RECEPTOR KIR3DL2 CONTRIBUTES TO DELINEATE THE ACUTE‐TYPE AND IS A THERAPEUTIC TARGET IN ADULT T‐CELL LEUKEMIA/LYMPHOMA</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Cheminant, M. ; Lhermitte, L. ; Bruneau, J. ; Sicard, H. ; Bonnafous, C. ; Ortonne, N. ; Genestier, L. ; Gaulard, P. ; Palmic, P. ; Dussiot, M. ; Waast, L. ; Avettand‐Fenoel, V. ; Brouzes, C. ; Lepelletier, Y. ; Asnafi, V. ; Marçais, A. ; Hermine, O.</creator><creatorcontrib>Cheminant, M. ; Lhermitte, L. ; Bruneau, J. ; Sicard, H. ; Bonnafous, C. ; Ortonne, N. ; Genestier, L. ; Gaulard, P. ; Palmic, P. ; Dussiot, M. ; Waast, L. ; Avettand‐Fenoel, V. ; Brouzes, C. ; Lepelletier, Y. ; Asnafi, V. ; Marçais, A. ; Hermine, O.</creatorcontrib><identifier>ISSN: 0278-0232</identifier><identifier>EISSN: 1099-1069</identifier><identifier>DOI: 10.1002/hon.82_2630</identifier><language>eng</language><publisher>Chichester: Wiley Subscription Services, Inc</publisher><subject>Leukemia ; Lymphoma ; Potassium channels (inwardly-rectifying) ; Therapeutic applications</subject><ispartof>Hematological oncology, 2019-06, Vol.37 (S2), p.271-272</ispartof><rights>2019 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhon.82_2630$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhon.82_2630$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids></links><search><creatorcontrib>Cheminant, M.</creatorcontrib><creatorcontrib>Lhermitte, L.</creatorcontrib><creatorcontrib>Bruneau, J.</creatorcontrib><creatorcontrib>Sicard, H.</creatorcontrib><creatorcontrib>Bonnafous, C.</creatorcontrib><creatorcontrib>Ortonne, N.</creatorcontrib><creatorcontrib>Genestier, L.</creatorcontrib><creatorcontrib>Gaulard, P.</creatorcontrib><creatorcontrib>Palmic, P.</creatorcontrib><creatorcontrib>Dussiot, M.</creatorcontrib><creatorcontrib>Waast, L.</creatorcontrib><creatorcontrib>Avettand‐Fenoel, V.</creatorcontrib><creatorcontrib>Brouzes, C.</creatorcontrib><creatorcontrib>Lepelletier, Y.</creatorcontrib><creatorcontrib>Asnafi, V.</creatorcontrib><creatorcontrib>Marçais, A.</creatorcontrib><creatorcontrib>Hermine, O.</creatorcontrib><title>MEMBRANE EXPRESSION OF NK RECEPTOR KIR3DL2 CONTRIBUTES TO DELINEATE THE ACUTE‐TYPE AND IS A THERAPEUTIC TARGET IN ADULT T‐CELL LEUKEMIA/LYMPHOMA</title><title>Hematological oncology</title><subject>Leukemia</subject><subject>Lymphoma</subject><subject>Potassium channels (inwardly-rectifying)</subject><subject>Therapeutic applications</subject><issn>0278-0232</issn><issn>1099-1069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kM1K5EAQx5tFYceP075AwR4lWt2ZfB3bTOk00_kg04H11CRtwirqaLKyePMRPPiEPomR0aunour_qyr4MfaL4zFHFCd_N3fHsbAi9PEHm3FMEo9jmOywGYoo9lD44ifbG8drxCnDeMZeM8pOK5kT0J-yovVaFTkUZ5CvoKKUSlNUsFKVv9AC0iI3lTqtDa3BFLAgrXKShsAsCWQ6zd-eX8xFOTX5AtQa5EdSyZJqo1IwsjonAyoHuai1ATPRKWkNmuoVZUqe6IusXBaZPGC7fXMzdoefdZ_VZ2TSpaeLc5VK7TmOMXpNK6LLnvctisSFTdCGfRR2gZuHvA_i0O-ccNhxHgfcBS1PmsBxcTl3cRu3AUaRv89-b-_eD5uHx278Z683j8Pd9NIKMRcRFwL9iTraUm7YjOPQ9fZ-uLpthifL0X5ot5N2-6l9ov0t_f_qpnv6DrXLIv_aegcto3tF</recordid><startdate>201906</startdate><enddate>201906</enddate><creator>Cheminant, M.</creator><creator>Lhermitte, L.</creator><creator>Bruneau, J.</creator><creator>Sicard, H.</creator><creator>Bonnafous, C.</creator><creator>Ortonne, N.</creator><creator>Genestier, L.</creator><creator>Gaulard, P.</creator><creator>Palmic, P.</creator><creator>Dussiot, M.</creator><creator>Waast, L.</creator><creator>Avettand‐Fenoel, V.</creator><creator>Brouzes, C.</creator><creator>Lepelletier, Y.</creator><creator>Asnafi, V.</creator><creator>Marçais, A.</creator><creator>Hermine, O.</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7QP</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>201906</creationdate><title>MEMBRANE EXPRESSION OF NK RECEPTOR KIR3DL2 CONTRIBUTES TO DELINEATE THE ACUTE‐TYPE AND IS A THERAPEUTIC TARGET IN ADULT T‐CELL LEUKEMIA/LYMPHOMA</title><author>Cheminant, M. ; Lhermitte, L. ; Bruneau, J. ; Sicard, H. ; Bonnafous, C. ; Ortonne, N. ; Genestier, L. ; Gaulard, P. ; Palmic, P. ; Dussiot, M. ; Waast, L. ; Avettand‐Fenoel, V. ; Brouzes, C. ; Lepelletier, Y. ; Asnafi, V. ; Marçais, A. ; Hermine, O.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1080-ab27df1fb029c6a5b6f76e5c461f5863ec2c0e11851c5b19a5c12d4c8b8b50773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Leukemia</topic><topic>Lymphoma</topic><topic>Potassium channels (inwardly-rectifying)</topic><topic>Therapeutic applications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cheminant, M.</creatorcontrib><creatorcontrib>Lhermitte, L.</creatorcontrib><creatorcontrib>Bruneau, J.</creatorcontrib><creatorcontrib>Sicard, H.</creatorcontrib><creatorcontrib>Bonnafous, C.</creatorcontrib><creatorcontrib>Ortonne, N.</creatorcontrib><creatorcontrib>Genestier, L.</creatorcontrib><creatorcontrib>Gaulard, P.</creatorcontrib><creatorcontrib>Palmic, P.</creatorcontrib><creatorcontrib>Dussiot, M.</creatorcontrib><creatorcontrib>Waast, L.</creatorcontrib><creatorcontrib>Avettand‐Fenoel, V.</creatorcontrib><creatorcontrib>Brouzes, C.</creatorcontrib><creatorcontrib>Lepelletier, Y.</creatorcontrib><creatorcontrib>Asnafi, V.</creatorcontrib><creatorcontrib>Marçais, A.</creatorcontrib><creatorcontrib>Hermine, O.</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Hematological oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cheminant, M.</au><au>Lhermitte, L.</au><au>Bruneau, J.</au><au>Sicard, H.</au><au>Bonnafous, C.</au><au>Ortonne, N.</au><au>Genestier, L.</au><au>Gaulard, P.</au><au>Palmic, P.</au><au>Dussiot, M.</au><au>Waast, L.</au><au>Avettand‐Fenoel, V.</au><au>Brouzes, C.</au><au>Lepelletier, Y.</au><au>Asnafi, V.</au><au>Marçais, A.</au><au>Hermine, O.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MEMBRANE EXPRESSION OF NK RECEPTOR KIR3DL2 CONTRIBUTES TO DELINEATE THE ACUTE‐TYPE AND IS A THERAPEUTIC TARGET IN ADULT T‐CELL LEUKEMIA/LYMPHOMA</atitle><jtitle>Hematological oncology</jtitle><date>2019-06</date><risdate>2019</risdate><volume>37</volume><issue>S2</issue><spage>271</spage><epage>272</epage><pages>271-272</pages><issn>0278-0232</issn><eissn>1099-1069</eissn><cop>Chichester</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/hon.82_2630</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0278-0232 |
| ispartof | Hematological oncology, 2019-06, Vol.37 (S2), p.271-272 |
| issn | 0278-0232 1099-1069 |
| language | eng |
| recordid | cdi_proquest_journals_2242712203 |
| source | Wiley Online Library Journals Frontfile Complete |
| subjects | Leukemia Lymphoma Potassium channels (inwardly-rectifying) Therapeutic applications |
| title | MEMBRANE EXPRESSION OF NK RECEPTOR KIR3DL2 CONTRIBUTES TO DELINEATE THE ACUTE‐TYPE AND IS A THERAPEUTIC TARGET IN ADULT T‐CELL LEUKEMIA/LYMPHOMA |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T17%3A08%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MEMBRANE%20EXPRESSION%20OF%20NK%20RECEPTOR%20KIR3DL2%20CONTRIBUTES%20TO%20DELINEATE%20THE%20ACUTE%E2%80%90TYPE%20AND%20IS%20A%20THERAPEUTIC%20TARGET%20IN%20ADULT%20T%E2%80%90CELL%20LEUKEMIA/LYMPHOMA&rft.jtitle=Hematological%20oncology&rft.au=Cheminant,%20M.&rft.date=2019-06&rft.volume=37&rft.issue=S2&rft.spage=271&rft.epage=272&rft.pages=271-272&rft.issn=0278-0232&rft.eissn=1099-1069&rft_id=info:doi/10.1002/hon.82_2630&rft_dat=%3Cproquest_cross%3E2242712203%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2242712203&rft_id=info:pmid/&rfr_iscdi=true |